New baldness cause accidentally discovered by scientists could lead to hair loss treatment – The Independent

A new cause of baldness has been accidentally discovered by scientists in the US in a breakthrough that could help develop a way to regrow hair.

The researchers were investigating the role played by anti-inflammatory immune cells called Tregs in skin health generally.

They found a way to temporarily remove the Tregs from the skin of laboratory mice, who had been shaved to allow the effects to be observed.

But the scientists then noticed something unexpected the hairfailed to grow back.

Previously it was thought that stem cells cause hairs to regrow after they fall out, but the team discoveredthat this only happens if Tregs are present.

One of the scientists, Professor Michael Rosenblum, an immunologist and dermatologist at University of California San Francisco, said: Our hair follicles are constantly recycling. When a hair falls out, the whole hair follicle has to grow back.

This has been thought to be an entirely stem cell-dependent process, but it turns out Tregs are essential.

If you knock out this one immune cell type, hair just doesn't grow.

Its as if the skin stem cells and Tregs have co-evolved, so that the Tregs not only guard the stem cells against inflammation but also take part in their regenerative work.

The stem cells rely on the Tregs completely to know when it's time to start regenerating.

The researcher believe that defects in Tregs could be responsible for the immune disease, alopecia areata, which causes hair to fall out in patches and possibly also play a part in other kinds of baldness.

The same stem cells that regrow hair are also involved in healing damage to the skin, so Tregs may also be involved in this process.

Tregs role as previously understood was mainly to regulate the immune system, helping it tell what to attack and what to leave alone.

When they malfunction it can lead to allergies to peanuts and other harmless substances or cause the immune system to attack the body.

Professor Rosenblum and colleagues had previously showed that Tregs help the immune systems of baby mice learn which skin microbes are not harmful and also that they secrete molecules that help heal wounds.

They were investigating these effects further when they noticed that patches of shaved hair on the lab mice were not regrowing.

We thought, Hmm, now thats interesting, Professor Rosenblum said. We realised we had to delve into this further.

Using sophisticated imaging techniques, the researchers were able to show that Tregs gathered around follicle stem cells at the start of the process to regrow a hair.

When Tregs were removed from the skin, this prevented the regrowth of hair but only if this was done within three days of the hair being shaved. After this time, the hair would regrow normally despite the absence of Tregs.

The cause of alopecia is poorly understood, but previous studies have showed genes associated with the condition are mostly related to Tregs. Boosting Treg function has been found to help.

Professor Rosenblum suggested further research into Tregs role could lead to improved treatments for hair loss generally and better understanding of their role in wound healing.

We think of immune cells as coming into a tissue to fight infection, while stem cells are there to regenerate the tissue after it's damaged, he said.

But what we found here is that stem cells and immune cells have to work together to make regeneration possible.

The research was described in the journal Cell.

See the original post here:
New baldness cause accidentally discovered by scientists could lead to hair loss treatment - The Independent

Stem Cell Research in Hair Loss – Financial Tribune

Researchers at Royan Institute have taken a step towards stem cell treatment of hair loss through laboratory studies on rats. Dermal papillas are small ridges at the surface of the skin, and in the scalp, which provide oxygen and nutrients to hair follicles so that healthy new hair may grow. Epithelial stem cells(EpSCs) in thehairfollicle helpin normal hairfollicle growth cycle.Any damage to these cells is the main cause of hair loss. Researchers at the institute Irans leading center for stem cell research conducted experiments in which they cultivated dermal papilla and epithelial stem cellsextracted from the human scalp in laboratory conditions, Mehr News Agency reported. In the research, around 15 laboratory rats were divided into three groups: one received dermal papilla, the second simultaneously received both dermal papilla and epithelial stem cells, and the third (control group) did not receive any cells. Results published in the institutes Cell Journal showed that hair growth occurred in the two groups receiving cells, but in the group receiving both kinds of cells, the hair growth was more tangible and visible to the naked eye. It was also revealed that transplantation of stem cells effective on hair growth can cause hair growth in hairless rats. With further research and better understanding of hair growth mechanism in humans, researchers may find effective ways to treat hair loss, the institute said.

View post:
Stem Cell Research in Hair Loss - Financial Tribune

Why Tooth Banking Might Just Be The Next Wave In Stem Cell Research – UPROXX

Shutterstock

Uproxx knows that science, technology, engineering, and math (STEM) disciplines are driving the future of this planet forward. Every day, we see new ideas, fresh innovations, and bold trailblazers in these fields. Follow us this month as we highlight how STEM is shaping the culture of NOW.

Placentas, umbilical cords pretty much anything that comes out of a womans body is awesome in science speak. Stem cells are the master cells of the body, just waiting to help you out when you get sick. Theyre your own personal repair kit, but, like anything, time kind of screws them up. They become damaged or mutated thanks to environmental factors and the aging process and one day, they lose their incredible healing abilities altogether.

The good news is, science has finally tapped into the potential of stem cell research and, in doing so, scientists have found a solution for all that wasted power: babies. Yes, babies are disgusting blobs that poop, eat, and slobber their parents to an early grave, but those little devils also just happen to have a whole army of brand new stem cells still in their original packaging. The key is to get them before they sell out. (Im starting to equate body parts with consumerism and its getting creepy so Ill stop now.)

Placenta blood, placenta tissue, and cord blood are three sources of stem cells doctors are urging new parents to consider saving after the mom gives birth. They provide a range of cool benefits from treating certain forms of cancer to helping people heal from spinal cord injuries and they can be cryogenically frozen to help a body out whenever it needs some extra healing power. And yes, some people do eat them. Google it, there are recipes.

But while the placenta party has been raging for a while now, theres a new method of extracting stem cells that can be done all the way up into a persons teen years, and all it takes is a quick trip to the dentist. Tooth banking has become the latest way people are choosing to cryogenically secure their gene sequence.

In 2013, Songtao Shi, a dentist, was researching regenerative dentistry in a lab when Shi witnessed something extraordinary. He discovered that when you get a cavity, the dentin the inner, hard layer of your tooth that protects the nerve and pulp from exposure builds up. Basically, your tooth tries to protect itself by making more organic matter.

This led Shi to conclude that stem cells did, in fact, exist in teeth. A bit more study found that while stem cells in adult molars were able to create more dentin which is great if you want to re-grow lost teeth instead of paying a fortune for an implant baby teeth, or SHED cells (stem cells from human exfoliated deciduous teeth) contained a whole different set of code.

While cord blood and placenta tissue contain Hematopoietic stem cells which have been used for decades to treat over 80 different diseases, SHED cells contain mesenchymal stem cells which differentiate into nerve cells as well as bone, cartilage, muscle, and fat. Cord blood contains mesenchymal stem cells too, but according to Shis research, SHED cells were able to create something unusual, dentin osteogenic material a material thats not quite dentin, not quite bone but full of possibilities like the ability to reconstruct bone.

Extracting dental stem cells is a complicated and sensitive process. First, the soft tissue has to be extracted, then it has to be disinfected (spoiler alert: your mouth is a cesspool of germs). Scientists then drill through the enamel and dentin to get to the pulp of the tooth where all the stem cells like to hide out. They take the pulp out, digest it with an enzyme, and culture the cells.

Its a lot of work, but the payoff is huge. Even tiny bits of dental pulp can carry hundreds of millions of stem cells.

Shutterstock

See the article here:
Why Tooth Banking Might Just Be The Next Wave In Stem Cell Research - UPROXX

Stem Cell Research Experts Meet for Cellular Therapies Conference – KDLT News

SIOUX FALLS, S.D. Some of the greatest minds in stem cell research came together in Sioux Falls today. One of them is German Doctor Eckhard Alt, for the Cellular Therapies Conference at Sanford Health.

Alt has been working in stem cell research for 15 years focusing on using the healing power of stem cells from the patients own body. He says the cells can be used for common ailments like chronic back pain or knee arthritis and because stem cells are produced naturally, they often work better than traditional medicine.

If you take the early stem cells, which you find in every organ, you dont need to do artificial modification. You just let nature do what the teaching is and the microenvironment that means the side where you inject the cells will tell the new stem cells hey guys, here is heart, here is muscle, here is kidney And they will do the right job, said Dr. Eckhard Alt.

Alt is no stranger to Sanford, in 2015, he was named the leader of the Sanford project, which aims to find a cure for type one diabetes.

Read more from the original source:
Stem Cell Research Experts Meet for Cellular Therapies Conference - KDLT News

Republicans Want Trump to Fire NIH Director Who Supports Embryonic Stem Cell Research – LifeNews.com

Republicans in Congress are urging President Donald Trump to oust the director of the National Institutes of Health because of his support for embryonic stem cell research that involves the destruction of human life.

40 Republicans in the House of Representatives wrote president Trump urging him to get rid of NIH director Francis Collins because of his support for the practice, which is opposed by pro-life organizations.

While pro-life advocates strongly support scientific research, they oppose embryonic stem cell research because the only way to obtain embryonic stem cells is to destroy unique human beings just days after conception. On the other hand, ethical adult stem cell research has produced cures or treatments for well over 100 diseases or medical conditions and involves no destruction of human life. Embryonic stem cell research has still yet to treat a single human being successfully.

Here is more from Politico:

Forty House Republicans are urging President Donald Trump to fire the director of the NIH over his support for embryonic and stem cell research that they say conflicts with Trumps pro-life direction.

The Republican House members, in a letter led by Rep. Jim Banks (R-Ind.), question NIH Director Francis Collins support for embryonic cloning and for stem cell research that involves the destruction of human embryos.

SUPPORT PRO-LIFE NEWS! Please help LifeNews.com with a donation

While we deeply respect Dr. Collins Christian faith and commitment to public service, the stances that Dr. Collins has taken in the past regarding embryonic stem cell research and human cloning are not life-affirming and directly conflict with the pro-life direction of your new presidency, the GOP lawmakers wrote. It is because of this troubling paradox that we ask you to re-consider his leadership role at NIH.

Collins has led the NIH since 2009, when he was unanimously confirmed by the Senate.

It has been unclear whether Trump will keep Collins, who came in at the beginning of the Obama administration, at the helm of the biomedical research institution. But Collins has wide support from both Republicans and Democrats.

In fact, several top Republicans former House Energy and Commerce Chairman Fred Upton, Senate HELP Chairman Lamar Alexander and key health care appropriators such as Sen. Roy Blunt and Rep. Tom Cole asked Trump in December to keep Collins.

But the 40 Republicans argue Collins doesnt share in their partys position on embryonic research. They wrote that Collins stance is particularly disturbing considering that NIHs funding for human embryonic stem cell research increased from $146 million in 2012 to $180 million in 2015.

The Obama administration forced Americans to pay for embryonic stem cell research involving the destruction of human life. National Institutes of Health chief Francis Collins approved taxpayer funding of dozens of lines of embryonic stem cells. The cells can only be obtained by destroying unborn children days after conception at which point human embryos are unique human beings.

Obama issued an executive order overturning the limits President Bush put in place on any new embryonic stem cell research funding. Bush directed federal dollars mostly to adult stem cells that are already helping patients now.

The Family Research Council responded to the Obama administrations move by saying that adult stem cells are already helping diabetes patients.

Of course, when it comes to juvenile (type I) diabetes, adult stem cells have already shown success at treating diabetes patients, the pro-life group noted.

It added, Interestingly, none of the human embryonic stem cell lines approved thus far are from the original group of 21 lines that had been receiving NIH funding, only one (H1one of the original five Thomson lines) has been submitted for approval, with only two other lines from Cellartis supposedly to be submitted for review.

This is surprising given that the vast majority of human embryonic stem cell research has been done with those previous lines, thus forcing most embryonic stem cell researchers to start over on experiments with new lines the group continued.

It also shows that this gold rush is just that, an attempt to grab more money built on embryo destruction, not built on science, FRC concluded.

Visit link:
Republicans Want Trump to Fire NIH Director Who Supports Embryonic Stem Cell Research - LifeNews.com

ESC-Track: A computer workflow for 4-D segmentation, tracking, lineage tracing and dynamic context analysis of ESCs – BioTechniques.com

ESC-Track: A computer workflow for 4-D segmentation, tracking, lineage tracing and dynamic context analysis of ESCs

Laura Fernndez-de-Manel1, Covadonga Daz-Daz2, Daniel Jimnez-Carretero1, Miguel Torres2, and Mara C. Montoya1

1Cellomics Unit 2Cardiovascular Developmental Program, Cell & Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares CNIC, Madrid, Spain

BioTechniques, Vol. 62, No. 5, May 2017, pp. 215222

Abstract

Embryonic stem cells (ESCs) can be established as permanent cell lines, and their potential to differentiate into adult tissues has led to widespread use for studying the mechanisms and dynamics of stem cell differentiation and exploring strategies for tissue repair. Imaging live ESCs during development is now feasible due to advances in optical imaging and engineering of genetically encoded fluorescent reporters; however, a major limitation is the low spatio-temporal resolution of long-term 3-D imaging required for generational and neighboring reconstructions. Here, we present the ESC-Track (ESC-T) workflow, which includes an automated cell and nuclear segmentation and tracking tool for 4-D (3-D + time) confocal image data sets as well as a manual editing tool for visual inspection and error correction. ESC-T automatically identifies cell divisions and membrane contacts for lineage tree and neighborhood reconstruction and computes quantitative features from individual cell entities, enabling analysis of fluorescence signal dynamics and tracking of cell morphology and motion. We use ESC-T to examine Myc intensity fluctuations in the context of mouse ESC (mESC) lineage and neighborhood relationships. ESC-T is a powerful tool for evaluation of the genealogical and microenvironmental cues that maintain ESC fitness.

Stem cells provide essential functions during embryonic development and tissue regeneration. Mouse embryonic stem cells (mESCs) are derived from pluripotent cells of the early mouse embryo and can be maintained as stable cell lines with a high self-renewal capacity. They provide a versatile in vitro model for understanding differentiation of human tissues, and their study has led to major advances in cell and developmental biology (1,2). A key challenge in the field is to understand the mechanisms involved in guiding stem cell fate (3-5), which have broad applications in biomedicine, from elucidating the causes of cancer to the use of stem cells in regenerative medicine. Thus, the biological properties of ESCs are a matter of great scientific, commercial, and medical interest.

ESC-Track (ESC-T) is a computational tool for automated segmentation and tracking of single mouse embryonic stem cells (mESCs) from live-cell 4-D confocal image data sets. The ESC-T workflow enables the extraction of parameters related to fluorescence signal localization and dynamics, cellular morphology, and cell motion for individual cells in the context of lineage and neighborhood relationships.

Optical imaging advances have led to the emergence of powerful live imaging tools with individual cell resolution in three-dimensional (3-D) space and in time (3-D + time or 4-D) (6,7). Moreover, a new generation of fluorescent proteins and dyes allows biochemical characterization of signaling pathways in intact living cells (8). Tagging by fluorescent proteins enables positional tracking of any given cell over time, which is easily achieved when the population of tagged cells is distributed among non-expressing cells by virtue of lineage or in experimental mosaics, but it becomes challenging when a fluorescent protein label is widely expressed (9). The ability to track and analyze live cells in time-lapse 4-D microscopy images is a matter of intense research (10,11) since visual inspection and analysis are insufficient to extract meaningful insights, making automated tracking and quantitative analysis of cells an absolute requirement. This is such a challenging task that several competitions have been carried out in order to evaluate cell segmentation and tracking algorithms (12,13). Computational tools are essential for extracting quantitative measurements from stem cell populations growing in 3-D physiological conditions and to translate the measurements into biological knowledge, allowing the study of a range of cell behaviors, such as motility, cell division, death, phagocytosis, etc. Most of these methods have been applied to Drosophila (14-18) and zebrafish (19-21) embryogenesis, or plant morphogenesis (22) studies. Of special relevance to the field of stem cell biology is the ability to integrate the cell behavior analysis with information about lineage (parentprogeny) and contextual (neighborhood) cellular relationships (9,11). In the last decade, several generic processing and tracking packages, such as Icy (23), Cell Profiler (24), tTt (25), qTfy (25), or the Fiji plugin TrackMate (26,27) have been reported. Some complex methods have been developed for specific applications, such as MARS (22), ACME (21), EDGE-4-D (17), and RACE (18) for particle (28), nuclear (16,29) or cellular (17,18,20-22) segmentation, and STARRYNITE (29), U-TRACK (28), ALT (22), EDGE-4-D (17), and TGMM (16) for tracking.

Here, we present a computational workflow that allows the automated segmentation and tracking of individual mESCs from live-cell 4-D confocal image data sets based on the combination of membrane and non-homogeneous nuclear signals, allowing lineage and neighborhood reconstruction. The workflow enables the extraction of parameters for fluorescence signal localization and dynamics, cellular morphological characteristics, and motion-related aspects of individual cells in the context of lineage and neighborhood relationships. ESC-T was used to study Myc dynamics in mESC cultures, and it proved to be a very valuable computational tool for stem cell research as it allowed the evaluation of genealogical and microenvironmental cues during mouse ESC culture in an unprecedented manner.

Automatic cell and nuclei segmentation and cell tracking. The proposed pipeline (Figure 1) uses images obtained from ESCs expressing tdTomato and GFP-MYC signals as described in the Supplementary Material. The pre-processing step consists of median filtering combining both nuclear and membrane signals (mycGFP median minus tdTomato median) (Figure 1, Steps 14) and is followed by application of a 2-D watershed segmentation algorithm, rendering 2-D sets (cell portions) (Figure 1, Step 5). Spatiotemporal (3-D + t) association rules based on the overlap of sets are applied to connect sets in 3-D space and time for automatic segmentation and tracking through the following pipeline:

View original post here:
ESC-Track: A computer workflow for 4-D segmentation, tracking, lineage tracing and dynamic context analysis of ESCs - BioTechniques.com

Feinstein Institute presents Cerami Award to Sir Paul Nurse for cancer research – University of Bristol

Northwell Health's Feinstein Institute for Medical Research and Molecular Medicine announced this week that the seventh Anthony Cerami Award in Translational Medicine will be awarded to Sir Paul Nurse, Director of The Francis Crick Institute and Chancellor of the University of Bristol.

The award is in recognition of his research, which identified protein molecules that control the division (duplication) of cells in the cell cycle currently being examined as a therapy to stop or prevent cancer cell growth.

Dr Nurse's research led to the critical discovery that the protein, cyclin-dependent protein kinase (CDK), found both in yeast and in human genes, controls the cell cycle or cell growth process. Knowledge of the cell cycle is critical to the treatment of cancer.

Most cancers are caused by the uncontrolled cell division due to damage to the controls regulating cell growth and reproduction, or by damage to how the cell replicates and grows. Leading drug companies are utilising the understanding of the role that CDK plays in cell growth to test new therapies to stop cancer cell growth.

Kevin J. Tracey, MD, president and CEO of the Feinstein Institute, editor emeritus ofMolecular Medicine, and Cerami Award committee member, said: "The Anthony Cerami Award in Translational Medicine was established to recognise investigators who provide the crucial early knowledge that inspires further research and leads to new therapies.

"Dr Nurse's discovery of CDK is a fundamental advance that is now helping the development of targeted treatments for cancer."

The Cerami Award, which includes a $20,000 prize, is conferred semi-annually by the editors ofMolecular Medicine, a peer-reviewed, open-access journal published by the Feinstein Institute. A monograph authored by Dr Nurse titled, "A Journey in Science: Cell Cycle Control," has been published on the Molecular Medicine website.

Dr Nurse said: "It is an honor to be recognised as an Anthony Cerami Award winner for my work on CDK and its impact on cancer.

"When deciding on a course of study, it has been my belief that it is essential to tackle a significant research problem, one that if solved could make a difference. I'm happy to tell my story to inspire investigators on their path to making a difference."

The Feinstein Institute is committed to celebrating the stewardship of the scientific process and imparting that perspective to young scientists.

It also recognises that the story behind making a discovery in medicine or health care should be cherished and broadly shared.

The goal of the Cerami Award and its associated monographs is to document the thinking leading to such innovations and discoveries so that these stories can endure and inspire future generations of investigators.

The Anthony Cerami Award in Translational Medicine was made possible by the generosity of Dr Cerami and the Ann Dunne Foundation for World Health. Dr Cerami's breakthrough translational work includes the identification of anti-TNF's potential to treat a number of inflammatory diseases, including rheumatoid arthritis, and the development of the HbA1c Diagnostic Test, currently the gold standard for the diagnosis and control of diabetes. He is currently working on a potential treatment of diabetes as CEO of Araim Pharmaceuticals.

AboutMolecular Medicine

Molecular Medicineis an open access, international, peer-reviewed biomedical journal published by The Feinstein Institute for Medical Research.Molecular Medicinepromotes the understanding of normal body functioning and disease pathogenesis at the cellular and molecular levels, allowing researchers and physician-scientists to use that knowledge in the design of specific tools for disease diagnosis, treatment, prognosis, and prevention. For more information, visitmolmed.org.

About the Feinstein Institute

The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 3,500 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine - a new field of science that has the potential to revolutionise medicine. For more information about how we empower imagination and pioneer discovery, visitFeinsteinInstitute.org

View post:
Feinstein Institute presents Cerami Award to Sir Paul Nurse for cancer research - University of Bristol

Researchers identify ‘signal’ crucial to stem cell function in hair follicles – Medical Xpress

May 24, 2017 by Collene Ferguson Jeff Biernaskies research identifies a factor essential for dermal stem cells to continuously divide during tissue regeneration. Credit: Riley Brandt, University of Calgary

Stem cell researchers at the University of Calgary have found another piece of the puzzle behind what may contribute to hair loss and prevent wounds from healing normally.

Jeff Biernaskie's research, published recently in the scientific journal npj Regenerative Medicine identifies a key signalling protein called platelet-derived growth factor (PDGF). This protein is critical for driving self-renewal and proliferation of dermal stem cells that live in hair follicles and enable their unique ability to continuously regenerate and produce new hair.

"This is the first study to identify the signals that influence hair follicle dermal stem cell function in your skin," says Biernaskie, an associate professor in comparative biology and experimental medicine at the University of Calgary'sFaculty of Veterinary Medicine, and Calgary Firefighters Burn Treatment Society Chair in Skin Regeneration and Wound Healing. Biernaskie is also a member of the Alberta Children's Hospital Research Institute.

"What we show is that in the absence of PDGF signalling hair follicle dermal stem cells are rapidly diminished because of their inability to generate new stem cells and produce sufficient numbers of mature dermal cells within the hair follicle."

Biernaskie and his team of researchers study dermal stem cells located within hair follicles. They are looking to better understand dermal stem cell function and find ways to use these cells to develop novel therapies for improved wound healing after injury, burns, disease or aging.

This study, co-authored byRaquel Gonzalez and Garrett Moffatt,shows that PDGF is key to maintaining a well-functioning stem cell population in skin. And in normal skin, if you don't have enough of it the stem cell pools start to shrink, meaning eventually the hair will no longer grow and wounds will not heal as well.

"It's an important start in terms of how we might modulate these cells towards developing future therapies that could regenerate new dermal tissue or maintain hair growth" says Biernaskie.

Biernaskie's lab is looking at the potential role of stem cells in wound healing and the potential to stimulate these cells to improve skin regeneration, as opposed to forming scars.

Explore further: Using stem cells to grow new hair

More information: Raquel Gonzlez et al. Platelet-derived growth factor signaling modulates adult hair follicle dermal stem cell maintenance and self-renewal, npj Regenerative Medicine (2017). DOI: 10.1038/s41536-017-0013-4

In a new study from Sanford-Burnham Medical Research Institute (Sanford-Burnham), researchers have used human pluripotent stem cells to generate new hair. The study represents the first step toward the development of a cell-based ...

If the content of many a situation comedy, not to mention late-night TV advertisements, is to be believed, there's an epidemic of balding men, and an intense desire to fix their follicular deficiencies.

UT Southwestern Medical Center researchers have identified the cells that directly give rise to hair as well as the mechanism that causes hair to turn gray findings that could one day help identify possible treatments ...

Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in skin cells of limited quantities in humans, which helps hair follicles form and regenerate ...

In experiments in mice, UC San Francisco researchers have discovered that regulatory T cells (Tregs; pronounced "tee-regs"), a type of immune cell generally associated with controlling inflammation, directly trigger stem ...

(Medical Xpress)A team of researchers with the Icahn School of Medicine at Mount Sinai in New York has found that giving a certain antibody to menopausal mice resulted in less weight gain and reduced bone loss. In their ...

A new study has uncovered a molecular mechanism in the prion protein, a protein responsible for neurodegenerative diseases, which may explain why nerve cells degenerate in these disorders.

Blood platelets shore up open wounds and help cuts heal, but they can also cause heart attacks and strokes when a congealed ball of platelets known as a thrombus breaks free from a site of injury and gets lodged in blood ...

(Medical Xpress)A European team of researchers working at Sweden's Karolinska Institutet has found evidence that suggests that humans have an olfactory defense against contagious diseases. In their paper published in Proceedings ...

A 12-month study mapping bacterial diversity within a hospitalwith a focus on the flow of microbes between patients, staff and surfacesshould help hospitals worldwide better understand how to encourage beneficial microbial ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Originally posted here:
Researchers identify 'signal' crucial to stem cell function in hair follicles - Medical Xpress

Stem Cell Therapy – State of the art treatment for pain

In most cases, 2 oz. (60 cc) of bone marrow aspirate is required. The aspirate includes platelets, mesenchymal stem cells, and other kinds of stem cells used in adult stem cell therapy. After aspiration, the stem cell tissue is separated from non-useful substances and cells via multiple filtration techniques. The bone marrow is placed inside a special container, which in turn is placed into a machine known as a centrifuge. The centrifuge spins the material at a high rate of speed, and this process separates the platelets and stem cells from the remainder of the blood products. It is this concentration of bone marrowcalled BMAC, or bone marrow aspiration concentrate that is injected to the site of tissue damage or injury. We use ultrasound and nerve stimulator guidance to increase the accuracy of administration

Once introduced, the platelets then release signal proteins and growth factors which activate the stem cells to divide rapidly. Stem cells by themselves are unable to repair the injured area. These cells have to be properly directed, and platelets perform this function. In effect, stem cells are construction workers and the platelets are their supervisors. Once they are activated, these stem cells perform a variety of valuable functions. Apart from repairing damage to the injured areas, they help damaged cells repair themselves and participate in the repairing process.

See the rest here:
Stem Cell Therapy - State of the art treatment for pain

Cold virus, stem cells tested to destroy deadly brain cancer – Medical Xpress

May 25, 2017 by Kristin Samuelson Killer T cells surround a cancer cell. Credit: NIH

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma.

The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor.

"We have discovered that combining stem cells with a virus causes the new drug to react like a cancer-seeking missile targeting cancerous cells in the brain" said principal investigator, Dr. Maciej Lesniak, the Michael J. Marchese Professor and chair of neurological surgery at Northwestern University Feinberg School of Medicine and a neuro-oncologist at Northwestern Medicine. "If it works in humans, it could be a powerful weapon against brain cancer and an option that our patients are desperate for."

One reason malignant glioma recurs so often is because a small subpopulation of cancer cells, often deep in the brain tissue, is highly resistant to chemotherapy and radiation.

The pre-clinical work done by Lesniak and his team has shown that the approach being tested at Northwestern Medicine can target this population of therapy resistant cells, further delaying and sometimes even preventing tumor recurrence.

The stem cells used in the research came from a collaboration of researchers from City of Hope.

The video will load shortly

"We haven't seen significant progress in the last decade for patients with a brain tumor, and that is why it's crucial to do everything we can to find a better treatment for brain tumors," said Dr. Roger Stupp, a co-investigator who is working alongside Lesniak on this clinical trial. "Combining novel therapy with medical expertise, we are able to get one step closer to eradicating this lethal disease."

Stupp, a world-renowned neuro-oncologist, recently joined Northwestern Medicine as director of neuro-oncology and associate director for strategic initiatives at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He is best known for developing temozolomide in combination with radiation as the standard-of-care chemotherapy for patients with glioblastoma.

Lesniak and his team of scientists are starting to test the safety and dosage of the treatment in patients at Northwestern Memorial Hospital. Lesniak began the research more than a decade ago while at the University of Chicago and completed it when he moved to Northwestern in 2015.

This investigational new drug contains neural stem cells to deliver a potent virus responsible for the common cold, oncolyotic adenovirus, which is engineered to kill brain cancer cells. The novel treatment works synergistically with chemotherapy and radiation to enhance the standard cancer treatments effectiveness.

Malignant gliomas are the most aggressive forms of cancer and are predicted to affect nearly 20,000 new patients this year, according to the American Brain Tumor Association. Sometimes called the "grow-and-go" tumors, gliomas can make their own blood supply, which fuels the tumors' rapid growth and helps them hatch satellite tumors. Each tumor sends out tentacles that infiltrate and dig deep into normal brain tissue, making complete removal of cancerous cells impossible. Any cancerous cells in the brain left over from standard of care can cause the tumor to recur.

Lesniak plans to enroll up to 36 newly diagnosed patients with glioma. These patients will be divided into two groups: those with tumors that can be removed and those where the tumors are not removable by surgery.

Next step, Northwestern Memorial will extend this research to the collaborating partners at City of Hope Comprehensive Cancer Center in Duarte, California.

Explore further: Neuroscientists pinpoint key gene controlling tumor growth in brain cancers

Cedars-Sinai investigators have identified a stem cell-regulating gene that affects tumor growth in patients with brain cancer and can strongly influence survival rates of patients. The findings, published in the online edition ...

Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor. The tumor is always fatal and primarily strikes children under 10 years old.

Chicago...Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) - a highly ...

Japanese researchers identify process to improve fluorescence detection of cancer stem cells, which are primarily responsible for brain tumor progression and recurrence after treatment

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain ...

Marc Symons, PhD, professor in The Feinstein Institute for Medical Research's Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used ...

Cancer is an extremely complex disease, but its definition is quite simple: the abnormal and uncontrollable growth of cells. Researchers from the University of Rochester's Center for RNA Biology have identified a new way ...

All cancer tumors have one thing in common - they must feed themselves to grow and spread, a difficult feat since they are usually in a tumor microenvironment with limited nutrients and oxygen. A study at The University of ...

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients ...

Scientists say they've developed a new blood test for identifying pancreatic cancera step that might eventually allow earlier diagnosis.

While target therapies directed toward genetic mutations that drive a tumor's growth have significantly improved the outlook for many patients, they have not been as successful in controlling brain metastases in several types ...

Cancers can be viewed as complex dynamic systems because they have many interacting parts that can change over time and space. Perhaps the most well-known complex dynamic system is the weather and, similar to weather forecasting, ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Follow this link:
Cold virus, stem cells tested to destroy deadly brain cancer - Medical Xpress